-
FDA announces plans to relax rules about copycat drugs
01 Nov 2025 17:34 GMT
… of some high-priced medications, in an effort … drugs already have biosimilar versions, including Herceptin for breast cancer, Lantus for insulin … and lengthy clinical trials to prove that … their profits.
"The pharmaceutical industry rigged the rules,…
-
Insulin Market Top Players, Segments & Regional Trends By 2034
31 Oct 2025 06:49 GMT
…
Julphar Diabetes
The United Laboratories International Holdings Limited.
Tonghua Dongbao Pharmaceutical Co … Insulin
By Applications (2026-2034)
Type I Diabetes
Type II Diabetes
Gestational Diabetes
Pre-diabetes …
-
How Much Will California’s State-Branded Insulin Cost?
30 Oct 2025 14:52 GMT
… insulin at a significantly lower rate than current medications for diabetes treatment … to produce generic pharmaceuticals.
In 2024, … pack. Lantus, Sanofi’s branded insulin, costs pharmacies … prescription drug prices, especially for drugs like insulin. Their …
-
Comparable Insulin Glargine Biosimilar Could Help Relieve Diabetes Costs
28 Oct 2025 00:52 GMT
… (Lantus) in adults living with type 2 diabetes, … health plan members.
Trial Participants and Methodology
… existing oral antidiabetic medications. Insulin dosing was individually … tested positive for treatment-induced anti-insulin antibodies (AIA) …
-
Affordable CalRx® Insulin, $11 a Pen, Will Soon Be Available for Purchase in California
25 Oct 2025 12:03 GMT
… effort to lower prescription drug prices and improve medication access statewide.
Through … management of diabetes. The CalRx insulin glargine pens are interchangeable with Lantus®, ensuring … of Medicaid cuts from H.R. 1, a lower cost insulin will …
-
California to Offer $ 11 Insulin
24 Oct 2025 03:03 GMT
… insulin. The CalRx insulin glargine pens are interchangeable with Lantus, … reported not taking their medicines as prescribed at … -the-counter drug instead, or cutting pills in half … for people living with insulin-dependent diabetes,” Christine Fallabel, MPH, …
-
To Lower Costs, California Will Start Selling Its Own Insulin
23 Oct 2025 02:03 GMT
… lowering drug costs and improving access for residents with diabetes.
… medication more affordable for Californians, particularly those struggling with high insulin … access to essential drugs while challenging entrenched pharmaceutical pricing practices.
…
-
Biocon Biologics eyes expansion in the US insulin market
22 Oct 2025 12:02 GMT
… promote, and sell the medicine in California under the CalRx … and only interchangeable biosimilar insulin glargine pen approved in … for its reference drug (in this case, Lantus by Sanofi) … Food and Drug Administration approval for rapid-acting insulin aspart ( …
-
Governors Briefs: CalRx® Insulin, $11 a Pen, Will Soon be Available and Appointment Announced
21 Oct 2025 23:11 GMT
… to lower prescription drug prices and improve medication access statewide.
… of diabetes. The CalRx insulin glargine pens are interchangeable with Lantus®, … Sweet was a senior trial attorney at Cellino & … Sweet earned a Juris Doctor degree from Loyola Law …
-
California to Offer Low-cost Insulin at $11 per Pen Starting in 2026
20 Oct 2025 22:02 GMT
… reported not taking their medicines as prescribed at … insulin. The CalRx insulin glargine pens are interchangeable with Lantus, … -the-counter drug instead, or cutting pills in half … for people living with insulin-dependent diabetes,” Christine Fallabel, MPH, …